Cloning and purification of an anti-thrombotic, chimeric Staphylokinase in Pichia pastoris-Reference-Cited by-同舟云学术

Cloning and purification of an anti-thrombotic, chimeric Staphylokinase in Pichia pastoris

Published:2019-10 Issue: Volume:162 Page:1-8
ISSN:1046-5928
Container-title:Protein Expression and Purification
language:en
Short-container-title:Protein Expression and Purification

Author:

Vandana ,Kantipudi Satish,Maheshwari Neeraj,Sharma Sheetal,Sahni Girish

Funder

CSIR

Publisher

Elsevier BV

Subject

Biotechnology

Reference74 articles.

1. The evolution of recombinant thrombolytics: current status and future directions;Adivitiya;Bioengineered,2017

2. beta-hydroxyaspartic acid or 6-hydroxyasparagine in bovine low density lipoprotein receptor and in bovine thrombomodulin*;Stenflos;J. Biol. Chem.,1988

3. Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis;Eisenberg;J. Am. Coll. Cardiol.,1986

4. Prognostic significance of fibrinopeptide a in survivors of cerebral infarction;Landi;Stroke,1990

5. Paradoxic elevation of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite intense fibrinolysis;Eisenberg;J. Am. Coll. Cardiol.,1987

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An effective combination of codon optimization, gene dosage, and process optimization for high-level production of fibrinolytic enzyme in Komagataella phaffii (Pichia pastoris);BMC Biotechnology;2020-12

2. Corrigendum to ‘Cloning and purification of an anti-thrombotic, chimeric Staphylokinase in Pichia pastoris’ [Protein Expr. Purif. 162 (2019) 1–8];Protein Expression and Purification;2020-03